Fusion Antibodies
Fusion Antibodies is a CRO that offers a range of services covering all stages of therapeutic and diagnostic antibody development from target discovery to delivery of lead optimized commercial candidates suitable for cGMP scale up.
Partnering objectives:
Meet with potential companies looking to access our royalty free, fee-for-service antibody engineering expertise in:
Ab humanization
Ab sequencing
Biosimilar development
Transient & Stable cell line development
We are also seeking partnerships with companies interested in the area of EGFR pathway to develop our in-house double targeting humanized therapeutic Antibody Fsn1006.
Dr Paul Kerr
Managing Director
